Antibacterial activity of Lucilia cuprina maggot extracts and its extraction techniques

International Journal of Integrative Biology

Volumn 9, Issue 1, 2010, Pages 43-48

  Arora, Shuchi ^a,b   Sing, Lim Chu ^a,c   Baptista, Carl ^d  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Nanyang Technological University   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Antibacterial activity; Excretion secretion; Gaseous metabolites; Lucilia cuprina; Maggot therapy

Indexed keywords

NATURAL PRODUCT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; DEBRIDEMENT; ESCHERICHIA COLI; EXTRACT; LUCILIA CUPRINA; LUCILIA SERICATA; MAGGOT; MAGGOT THERAPY; NONHUMAN; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HEXAPODA; LUCILIA CUPRINA; LUCILIA SERICATA; STAPHYLOCOCCUS AUREUS;

EID: 77749319396     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. WHO (2002) Antimicrobial Resistance. Fact sheet No. 194.
2. Andrews JM (2001) Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 48(1): 5-16.
3. Baveja JK, Li G, et al. (2004a) Biological performance of a novel synthetic furanone-based antimicrobial. Biomaterials, 25(20): 5013-5021.
4. Baveja JK, Willcox MDP, et al. (2004b) Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials, 25(20): 5003-5012.
5. Bexfield A, Nigam Y, et al. (2004) Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes and Infection, 6(14): 1297-1304.
6. Boman HG (2000) Innate immunity and the normal microflora. Immunological Reviews, 173: 5-16.
7. Bulet P, Hetru C, et al. (1999) Antimicrobial peptides in insects; structure and function. Developmental and Comparative Immunology, 23(4-5): 329-344.
8. Cazander G, van Veen KEB, et al. (2009) Do maggots have an influence on bacterial growth? A study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions. Journal of Tissue Viability, 18(3): 80-87.
9. Daeschlein G, Mumcuoglu KY, et al. (2007) In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacology and Physiology, 20(2): 112-115.
10. Gupta A (2008) A review of the use of maggots in wound therapy. Annals of Plastic Surgery, 60(2): 224-227.
11. Huberman L, Gollop N, et al. (2007) Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Medical and Veterinary Entomology, 21(2): 127-131.
12. Jaklia D, Lapanje A, et al. (2008) Selective antimicrobial activity of maggots against pathogenic bacteria. Journal of Medical Microbiology, 57(5): 617-625.
13. Kerridge A, Lappin-Scott H, et al. (2005) Antibacterial properties of larval secretions of the blowfly, Lucilia sericata. Medical and Veterinary Entomology, 19(3): 333-337.
14. Knowles A, Findlow A, et al. (2001) Management of a diabetic foot ulcer using larval therapy. Nursing standard, 16(6): 73-76.
15. Levy SB and Marshall B (2004) Antibacterial resistance worldwide: Causes, challenges and responses. Nature Medicine, 10(12): S122-S129.
16. Livermore DM (2000) Antibiotic resistance in staphylococci. International Journal of Antimicrobial Agents, 16(S1): S3-S10.
17. Morozova NA, Sedavkina VA, et al. (1989) Antimicrobial activity of 5-alkyl-3H-furanones and their sulfur analogs. Pharmaceutical Chemistry Journal, 23(2): 147-149.
18. Mumcuoglu KY, Miller J, et al. (2001) Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae)" Journal of Medical Entomology, 38(2): 161-166.
19. Parnes A and Lagan KM (2007) Larval therapy in wound management: A review. International Journal of Clinical Practice, 61(3): 488-493.
20. Pavillard ER and Wright EA (1957) An antibiotic from maggots. Nature, 180(4592): 916-917.
21. Rayner K (1999) Larval therapy in wound debridement. Professional nurse, 14(5): 329-333.
22. Richardson M (2004) The benefits of larval therapy in wound care. Nursing standard, 19(7)
23. Schwalbe R, et al. (2007) Antimicrobial Susceptibility Testing Protocols, CRC Press, Taylor and Francis Group.
24. Sherman RA, Hall MJR, et al. (2000) Medicinal maggots: An ancient remedy for some contemporary afflictions. Annual Review of Entomology, 45: 55-81.
25. Simmons SW (1935a) The bacterial properties of excretions of the maggots of Lucilia sericata. Bulletin of Entomological Research, 26: 559-563.
26. Simmons SW (1935b) A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. Journal of Bacteriology, 30(3): 253-267.
27. Sung WS, Jung HJ, et al. (2007) 2,5-dimethyl-4-hydroxy-3(2H)- furanone (DMHF); antimicrobial compound with cell cycle arrest in nosocomial pathogens. Life Sciences, 80(6): 586-591.
28. Sutandar A, Lim CS, et al. (2008) System for real-time monitoring of mutation-in-progress. Journal of Applied Microbiology, 104(5): 1400-1407.
29. Thomas S, Andrews A, et al. (1999) The antimicrobial activity of maggot secretions: results of a preliminary study. Journal of Tissue Viability. 9: 127-132.
30. Turkmen A, Graham K, et al. (2009) Therapeutic applications of the larvae for wound debridement. Journal of Plastic. Reconstructive and Aesthetic Surgery, 63(1): 184-188.